Profile
Linda M.
Kozick is currently Director at Saugatuck Therapeutics Ltd. Former positions include Independent Director at Rapt Therapeutics, Inc. from 2016 to 2026, Independent Director at Artiva Biotherapeutics, Inc., Independent Director at AlphaTON Capital Corp.
from 2022 to 2024, and VP, Head-Immuno Oncology & Oncology Product at Bristol Myers Squibb Co. from 2011 to 2015.
Education includes an MBA from Chapman University and undergraduate and graduate degrees from SUNY Upstate Medical University.
Linda Kozick active positions
| Companies | Position | Start |
|---|---|---|
Saugatuck Therapeutics, Ltd. | Director/Board Member | - |
Former positions of Linda Kozick
| Companies | Position | End |
|---|---|---|
| RAPT THERAPEUTICS, INC. | Director/Board Member | 02/03/2026 |
| ALPHA COMPUTE CORP | Director/Board Member | 25/04/2024 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 30/06/2015 |
| ARTIVA BIOTHERAPEUTICS, INC. | Director/Board Member | - |
Training of Linda Kozick
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
AlphaTON Capital Corp.
AlphaTON Capital Corp. Packaged SoftwareTechnology Services Operates as an AI compute infrastructure company that provides hardware-enforced GPU as a service solutions | Technology Services |
Chapman University
Chapman University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SUNY Upstate Medical University
SUNY Upstate Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rapt Therapeutics, Inc.
Rapt Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oral small molecule therapies for patients | Health Technology |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
Saugatuck Therapeutics, Ltd. |
- Stock Market
- Insiders
- Linda Kozick
















